According to Grifols's latest financial reports the company has a price-to-book ratio of 0.5976.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.14 | 46.89% |
2022-12-31 | 0.7758 | -42.47% |
2021-12-31 | 1.35 | -36% |
2020-12-31 | 2.11 | -23.1% |
2019-12-31 | 2.74 | -7.92% |
2018-12-31 | 2.98 | -28.91% |
2017-12-31 | 4.19 | 30.06% |
2016-12-31 | 3.22 | -17.83% |
2015-12-31 | 3.92 | -2.12% |
2014-12-31 | 4.00 | -21.85% |
2013-12-31 | 5.12 | 23.74% |
2012-12-31 | 4.14 | 85.15% |
2011-12-31 | 2.23 | |
2010-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.20 | 770.92% | ๐บ๐ธ USA |
Amgen AMGN | 23.5 | 3,832.17% | ๐บ๐ธ USA |
Baxter BAX | 2.42 | 304.94% | ๐บ๐ธ USA |
Kimberly-Clark KMB | 43.0 | 7,097.90% | ๐บ๐ธ USA |